Biologically Active Sheep Colostrum for Topical Treatment and Skin Care

Int J Mol Sci. 2024 Jul 25;25(15):8091. doi: 10.3390/ijms25158091.

Abstract

Colostrum is gaining popularity in cosmetic products. The present study compared the composition and selected biological properties of colostrum from Polish sheep (colostrum 1) and Swiss sheep (colostrum 2), particularly those that can affect healthy or diseased skin. The antioxidant activity of the colostrums was measured using ABTS and DPPH assays. The effect on the proliferation of human skin fibroblasts, neonatal epidermal keratinocytes, and human diabetic fibroblast (dHF) cells isolated from diabetic foot ulcers was also assayed in vitro by MTT and Presto Blue tests, respectively. The colostrum simulated dHF cell proliferation by up to 115.4%. The highest used concentration of colostrum 1 stimulated normal fibroblast proliferation by 191.2% (24 h) and 222.2% (48 h). Both colostrums inhibited epidermal keratinocyte viability. The influence of the colostrums on the expression of genes related to proliferation (Ki67) and immune response (IL-6, PTGS-2, TSG-6) in dHF cells were compared. Colostrum 1 increased the rate of wound closure (scar test). Analysis of total fat, protein and fatty acid content found the Polish colostrum to be a richer source of fat than the Swiss colostrum, which contained a larger amount of protein. Both colostrums exhibit properties that suggest they could be effective components in cosmetic or medicinal formulations for skin care, especially supporting its regeneration, rejuvenation, and wound healing.

Keywords: antioxidant; cosmetic ingredients; fibroblasts; gene expression; keratinocytes; proliferation; scar test; sheep colostrum; skin diseases.

MeSH terms

  • Administration, Topical
  • Animals
  • Antioxidants / pharmacology
  • Cell Proliferation* / drug effects
  • Cell Survival / drug effects
  • Cells, Cultured
  • Colostrum* / chemistry
  • Diabetic Foot / drug therapy
  • Diabetic Foot / metabolism
  • Diabetic Foot / therapy
  • Female
  • Fibroblasts* / drug effects
  • Fibroblasts* / metabolism
  • Humans
  • Keratinocytes* / drug effects
  • Keratinocytes* / metabolism
  • Pregnancy
  • Sheep
  • Skin / metabolism
  • Skin Care* / methods
  • Wound Healing / drug effects

Substances

  • Antioxidants

Grants and funding

This research was supported by the Medical University of Lodz, grant No. 503/3-066-02/503-31-001.